Discovery Study
The purpose of this study is to test a new medication that is designed to help surgeons see the edges of tumours during surgery or find small tumours that they might not normally be able to see with their eyes.
Currently, surgeons must rely on their eyes when removing tumours from patients. This makes it difficult to tell the difference between tumour and normal tissue or to see very small tumours located away from the main tumour.
Before this medication can be used in surgery, it needs to be tested in healthy participants to assess its safety and how it is absorbed into the blood stream, under controlled conditions that are not possible during surgery. If approved, it is hoped that this medication will increase the chance of complete removal of the tumour, thereby reducing the likelihood that the cancer will come back.
The trial has been approved by an independent ethics committee and participants will be reimbursed for their time.